翔宇医疗
(688626)
| 流通市值：66.24亿 | | | 总市值：66.24亿 |
| 流通股本：1.60亿 | | | 总股本：1.60亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 538,778,424.77 | 373,167,985.72 | 193,080,689.91 | 767,747,443.44 |
| 营业收入 | 538,778,424.77 | 373,167,985.72 | 193,080,689.91 | 767,747,443.44 |
| 二、营业总成本 | 507,974,627.33 | 343,483,933.6 | 168,290,426.45 | 726,616,071.69 |
| 营业成本 | 173,250,668.65 | 120,783,000.04 | 61,397,644.19 | 256,205,489.55 |
| 税金及附加 | 9,546,578.3 | 6,286,447.57 | 3,070,270.82 | 13,233,453.8 |
| 销售费用 | 162,442,107.14 | 109,993,080.14 | 51,418,819.88 | 232,872,273.82 |
| 管理费用 | 51,725,447.3 | 32,442,009.04 | 16,128,262.25 | 65,110,864.12 |
| 研发费用 | 119,023,415.49 | 79,080,050.46 | 37,947,523.89 | 175,061,698.12 |
| 财务费用 | -8,013,589.55 | -5,100,653.65 | -1,672,094.58 | -15,867,707.72 |
| 其中:利息费用 | 3,159,686.33 | 2,704,110.5 | 2,208,760.73 | 5,695,731.79 |
| 其中:利息收入 | 11,120,238.15 | 7,895,852.75 | 4,564,336.92 | 23,015,837.85 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | - | 590,542.25 | - | 501,026 |
| 加:投资收益 | 5,384,502.64 | 6,279,726.16 | -1,327,129.01 | 5,939,079.55 |
| 资产处置收益 | 9,867.79 | 8,964.16 | -1,026.65 | 26,252.93 |
| 资产减值损失(新) | -7,602,754.52 | -4,325,780.07 | -1,361,027.35 | -8,064,545.2 |
| 信用减值损失(新) | -1,202,954.97 | -4,452,655.34 | -928,364.17 | -3,436,954.48 |
| 其他收益 | 23,438,808.14 | 15,754,052.31 | 5,537,729.15 | 40,612,286.1 |
| 四、营业利润 | 50,831,266.52 | 43,538,901.59 | 26,710,445.43 | 76,708,516.65 |
| 加:营业外收入 | 158,896.84 | 97,070.32 | 22,195.75 | 97,618.81 |
| 减:营业外支出 | 830,837.16 | 272,306.81 | 66,453.8 | 2,374,558.53 |
| 五、利润总额 | 50,159,326.2 | 43,363,665.1 | 26,666,187.38 | 74,431,576.93 |
| 减:所得税费用 | 5,494,632.71 | 3,469,325.41 | 1,766,226.46 | -1,555,369.11 |
| 六、净利润 | 44,664,693.49 | 39,894,339.69 | 24,899,960.92 | 75,986,946.04 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 44,664,693.49 | 39,894,339.69 | 24,899,960.92 | 75,986,946.04 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 44,872,142.82 | 39,656,233.75 | 25,322,010.2 | 78,156,441.97 |
| 少数股东损益 | -207,449.33 | 238,105.94 | -422,049.28 | -2,169,495.93 |
| 扣除非经常损益后的净利润 | 31,061,826.35 | 28,928,766.25 | 23,293,091.68 | 58,273,346.59 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.29 | 0.26 | 0.16 | 0.51 |
| (二)稀释每股收益 | 0.29 | 0.26 | 0.21 | 0.6 |
| 九、综合收益总额 | 44,664,693.49 | 39,894,339.69 | 24,899,960.92 | 75,986,946.04 |
| 归属于母公司股东的综合收益总额 | 44,872,142.82 | 39,656,233.75 | 25,322,010.2 | 78,156,441.97 |
| 归属于少数股东的综合收益总额 | -207,449.33 | 238,105.94 | -422,049.28 | -2,169,495.93 |
| 公告日期 | 2026-10-30 | 2026-08-29 | 2026-04-24 | 2026-04-24 |
| 审计意见(境内) | | | | 标准无保留意见 |